Warburg Pincus related stories
All articles and analysis
Deal-making sluggish as giants move down-marketDry powder abounds. So where is the explosion of deals?
Blackstone, Bain agree India secondary saleBlackstone made a reported 3x on the $112m sale of Emcure Pharmaceuticals to Bain Capital.
- Flurry of IPOs provides exits for some mega-buyouts; others languish
A flurry of recent initial public offerings has paved the way for successful exits for the sponsors of the some of the biggest leveraged buyouts of the past decade, but the fate of the remaining handful of companies in private equity portfolios remains uncertain at best.
Valeant Pharmaceuticals inks $250 mln deal to acquire PE-backed Solta MedicalMontréal-based specialty pharmaceutical company Valeant Pharmaceuticals International Inc (NYSE: VRX and TSX: VRX) has agreed to acquire Solta Medical Inc (NASDAQ: SLTM) for $2.92 per share in cash, which represents a 40% premium to Solta's closing share price on December 13, 2013, or about US$250 million. The Hayward, Calif.-based Solta Medical, a designer, developer and manufacturer of energy-based medical device systems for aesthetic applications, is a portfolio company of U.S. private equity firms Longitude Capital and Great Point Partners. The transaction is expected to close in the first quarter of 2014 . Earlier this year, Valeant bought /canada/2013/08/08/valeant-closes-8-7b-acquisition-bausch-lomb/ eye care specialist Bausch + Lomb Holdings Inc. from Warburg Pincus for US$8.7 billion.
- Sponsors more than double their money with debt-laden Aramark
Aramark Holdings, one of the big club deals from the last decade, completed its initial public offering on Dec. 12, and its private equity sponsors likely more than doubled the money they invested, sister news service peHUB reported.
- PE-owned Aramark debuts IPO
Aramark launched its IPO Thursday after pricing its offering of 36,250,000 shares of common stock at $20 per share. The stock is trading on the New York Stock Exchange under the symbol "ARMK." Goldman Sachs, J.P. Morgan Securities, Credit Suisse Securities and Morgan Stanley are serving as lead underwriters. Headquartered in Philadelphia, Aramark is a provider of food services, facilities management, and uniform and career apparel to health care. It is owned by Warburg Pincus, Thomas H. Lee Partners, GS Capital Partners and CCMP/JPMorgan Partners.
- Warburg tops up China investment to $200m
e-Shang has also secured a $120m pre-IPO loan from Goldman Sachs.
- Warburg completes $49m India deal
The firm has teamed with Faering Capital to acquire ethnic retailer BIBA Apparels.
Sponsors could double their money with debt-laden Aramark IPOAramark Holdings, one of the big club deals from the last decade, is slated to go public next week. The IPO would give Aramark's private equity investors a path to exit, but the food service provider will enter the public markets saddled with much debt.
- Willkie Farr & Gallagher hires top PE lawyer as partner
Willkie Farr & Gallagher said Thursday that it has named Kirk A. Radke as a partner in the firm’s private equity practice group. A top private equity lawyer, Radke will be based in the firm's New York office. Willkie Farr & Gallagher is an international law firm with approximately 600 attorneys.